Navigation Links
Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
Date:2/10/2012

ANAHEIM, Calif., Feb. 10, 2012  /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Leerink Swann Global Healthcare Conference to be held on February 15-16, 2012 in New York.  Steve Cartt, Executive Vice President and Chief Business Officer, is scheduled to present an overview of the Company on Thursday, February 16, 2012 at 2:30 p.m. ET. 

A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.  The replay will be available for 90 days after the event.

About Questcor                                                                                     

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product, Acthar, helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has appro
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Questcor Announces Third Quarter 2010 Earnings Release Date and Conference Call
2. Questcor Pharmaceuticals to Be Added to S&P SmallCap 600 Index
3. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 9, 2011
4. Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
7. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
8. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
9. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
10. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
11. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... RedBrick Health , a fast-growing leader in consumer health ... EmblemHealth , the New York -based ... RedBrick Compass health assessment, combined with the RedBrick Journeys ... EmblemHealth is among the first health plans in the ...
(Date:1/15/2014)... TX (PRWEB) January 15, 2014 More ... disease, and about 1 in 3 seniors will die ... source ). These jaw-dropping figures have shocked many Americans ... and, hopefully, help prevent these tragic age-related cognitive disorders. ...
(Date:1/15/2014)... DTS Language Services, Inc . is pleased to ... Science organizations who need document translations. Clients will now ... documents in advance with a selection of nearly 50 life ... a critical factor in clinical and scientific fields, and decrease ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 AudioNotch is ... new therapy for the treatment of tinnitus. Patients listen ... frequency, and over a period of weeks to months, their ... Therapy in two forms: Notched Music and Notched White Noise. ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2DTS Improves Efficiency for Life Science Document Translations 2
... Materials Research Science and Engineering Centers (MRSECs) awarded ... (solicitation NSF 07-563). , MRSECs support outstanding ... fundamental problems in science and engineering. These centers ... and level of interactions provided by a center. ...
... 3 /Xinhua-PRNewswire-FirstCall/ --,Pharmaceutical company Pharmaxis (ASX: PXS, NASDAQ: ... from its respiratory disease,program at the 2008 European ... the 4th to the 8th October. The ERS ... and clinicians to hear latest,advances in clinical diagnosis ...
... SyntheMed, Inc. (OTC,Bulletin Board: SYMD) announced today ... assumed the newly-created position of Executive,Chairman and Gere ... advisors,has assumed the newly-created position of Medical Director. ... involved with strategic,planning, external communications and Board leadership ...
Cached Biology Technology:NSF awards 14 materials research science and engineering centers 2Pharmaxis Research Programs Highlighted at European Respiratory Society Congress 2Pharmaxis Research Programs Highlighted at European Respiratory Society Congress 3SyntheMed Announces New Management Appointments 2
(Date:7/10/2014)... Cancer Research Centre (CNIO) Macromolecular Crystallography Group has ... called BuD to DNA in order to redirect ... researcher who led the study, says the discovery: ... instructions contained in the genome to treat genetic ... is published in the journal Acta Crystallographica, ...
(Date:7/10/2014)... natural-color satellite image was collected by the Moderate Resolution ... 10, 2014. Each hot spot, which appears as a ... on the MODIS instrument recognized temperatures higher than background. ... image, such hot spots are diagnostic for fire. ... little danger coming directly from the fires, although the ...
(Date:7/10/2014)... (July 10, 2014) Consuming a whole fresh avocado ... significantly enhanced provitamin A carotenoid (alpha- and beta-carotene) absorption ... of vitamin A, according to new research (1) ... , Vitamin A is involved in reproductive ... function, and vision; and has antioxidant properties. Provitamin A ...
Breaking Biology News(10 mins):CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2New research: Fresh avocado enhances absorption of essential nutrients for healthy living 2
... Fairbanks, Alaska -- As the Arctic warms, greenhouse gases ... significantly higher levels than previous estimates, according to survey ... 30 issue of the journal Nature. Permafrost thaw ... deforestation, say the authors, but the effect on ...
... of North Carolina at Chapel Hill have shown that it ... an effort to create the ultimate vehicle for gene therapy. ... side effects from using a "chimeric" virus to deliver replacement ... dystrophy. "This trial demonstrates that gene therapy is no ...
... , MONTREAL, November 30, 2011 Take a Petri dish ... distinctive of the toxins that make up the fossil fuel. ... sit for two weeks in an incubator, and surprise, the ... petroleum!" says Mohamed Hijri, a professor of biological sciences and ...
Cached Biology News:Abrupt permafrost thaw increases climate threat 2Clinical trial for muscular dystrophy demonstrates safety of customized gene therapy 2Petroleum-eating mushrooms 2Petroleum-eating mushrooms 3Petroleum-eating mushrooms 4
... System creates isogenic cell lines all ... the protein of interest. This homogeneous ... (click link below). In this experiment ... (CAT) was subcloned into pcDNA5/FRT and ...
Fast, sensitive quantitation of total MEK 1/2 concentration....
... for 50 L samples. Operating head automatically rises at the end of determination; triple-point calibration verification; refrigerator ... ... ... ...
SHEEP ANTI ESCHERICHIA COLI...
Biology Products: